MBRX icon

Moleculin Biotech

21 hedge funds and large institutions have $790K invested in Moleculin Biotech in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 1 closing their positions.

Holders
21
Holders Change
+3
Holders Change %
+16.67%
% of All Funds
0.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
6
Reduced
5
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
AC
1
Armistice Capital
New York
$540K 317,586 +27,586 +10%
LPL Financial
2
LPL Financial
California
$70.1K 41,215 +5,112 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$52.6K 30,935 -40,468 -57%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$37.5K 22,024 +206 +0.9%
BlackRock
5
BlackRock
New York
$21K 12,380 -95 -0.8%
Renaissance Technologies
6
Renaissance Technologies
New York
$19.5K 11,496 +500 +5%
Truist Financial
7
Truist Financial
North Carolina
$17.9K 10,500
UBS Group
8
UBS Group
Switzerland
$15.2K 8,939 +8,939 New
TRCT
9
Tower Research Capital (TRC)
New York
$6.84K 4,024 +2,213 +122%
AWM
10
Atticus Wealth Management
Florida
$4.73K 2,784 -550 -16%
NFSG
11
Newbridge Financial Services Group
Florida
$2.32K 1,367
Morgan Stanley
12
Morgan Stanley
New York
$724 426 -23 -5%
SS
13
SBI Securities
Japan
$689 405 +405 New
BWL
14
Bogart Wealth LLC
Virginia
$510 300 +300 New
Bank of America
15
Bank of America
North Carolina
$176 104 -39 -27%
SSB
16
Sandy Spring Bank
Maryland
$152 89
Osaic Holdings
17
Osaic Holdings
Arizona
$83 49 +26 +113%
CFO
18
CVA Family Office
Colorado
$58 34
KIM
19
Kestra Investment Management
Texas
$43 25 +25 New
NSIM
20
North Star Investment Management
Illinois
$29 17
JPMorgan Chase & Co
21
JPMorgan Chase & Co
New York
-1 Closed
CFGS
22
Concourse Financial Group Securities
Alabama
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
$0 1